Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, is pleased to announce it received a Silver Award at the 2022 Davey Awards for its “Build It Better: ePRO Accreditation Program.”
San Francisco, CA (August 19, 2022) — Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, has successfully completed a System and Organization Controls (SOC) 2 Type 2 examination. The independent third-party report attests to the controls at Medrio regarding the security, availability, and confidentiality of its eClinical technology and solutions.
San Francisco, CA, March 13, 2022 – Medrio announced today that they have joined The Association for Clinical Data Management (ACDM). Medrio is excited to become part of ACDM and engage globally
Medrio, Inc., a leading provider of decentralized and eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets and PHARMASEAL International Ltd., a provider of clinical trial management
Medrio, Inc. a leading provider of decentralized and eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets and PHASTAR, a global specialist biometrics clinical research organization (CRO)
PHARMASEAL International Ltd, a technology provider of clinical trial management and governance solutions for biopharmaceutical, CROs, and medical device organizations, and leading hybrid and decentralized trials software organization, Medrio have
Medrio, Inc., a leading provider of decentralized and eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, has been selected as the exclusive data management vendor for
Medrio Inc., the leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets announced today that it has acquired HMD Clinical, a leading provider of
Medrio Inc., the leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, announced the appointment of Nicole Latimer to Chief Executive Officer. Nicole will
Medrio, Inc., the leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, and Avance Clinical, the leading Australian CRO for biotechs have reached a
Medrio, Inc. the leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, has entered into a partnership with Hope Biosciences Stem Cell Research Foundation
MMS Holdings – an award-winning, data-focused contract research organization (CRO) – has successfully leveraged the support services provided by Medrio, the leading provider of eClinical technology for small to mid-sized pharmaceutical
Medrio, the leading provider of eClinical technology for early-phase pharma, medical device, and diagnostics clinical trials, has rolled out several significant updates to the Medrio Partner Program, a collaborative effort
Innovaderm Research, Inc., an innovative clinical research organization (CRO) specializing in dermatology, has finalized a deal to extend their use of Medrio, the leading provider of eClinical technology for early-phase
Medrio, Inc. a leading healthcare technology company providing eClinical solutions for clinical trials, announced today the company’s international and domestic channel expansion, which includes EMEA and APAC. On the heels
Sign up to have our the latest insights delivered to your inbox.
